Late-stage success for experimental migraine drug
admin 2nd January 2020 Uncategorised 0The results support the filing of a New Drug Application (NDA) for Axsome’s AXS-07 in the acute treatment of migraine.
More: Late-stage success for experimental migraine drug
Source: News